449 related articles for article (PubMed ID: 20798252)
1. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.
Büscher AK; Kranz B; Büscher R; Hildebrandt F; Dworniczak B; Pennekamp P; Kuwertz-Bröking E; Wingen AM; John U; Kemper M; Monnens L; Hoyer PF; Weber S; Konrad M
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2075-84. PubMed ID: 20798252
[TBL] [Abstract][Full Text] [Related]
2. Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
Büscher AK; Beck BB; Melk A; Hoefele J; Kranz B; Bamborschke D; Baig S; Lange-Sperandio B; Jungraithmayr T; Weber LT; Kemper MJ; Tönshoff B; Hoyer PF; Konrad M; Weber S;
Clin J Am Soc Nephrol; 2016 Feb; 11(2):245-53. PubMed ID: 26668027
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.
Santín S; Bullich G; Tazón-Vega B; García-Maset R; Giménez I; Silva I; Ruíz P; Ballarín J; Torra R; Ars E
Clin J Am Soc Nephrol; 2011 May; 6(5):1139-48. PubMed ID: 21415313
[TBL] [Abstract][Full Text] [Related]
4. Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.
Suvanto M; Patrakka J; Jahnukainen T; Sjöström PM; Nuutinen M; Arikoski P; Kataja J; Kestilä M; Jalanko H
Clin Exp Nephrol; 2017 Aug; 21(4):677-684. PubMed ID: 27573339
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
6. Causal and putative pathogenic mutations identified in 39% of children with primary steroid-resistant nephrotic syndrome in South Africa.
Nandlal L; Winkler CA; Bhimma R; Cho S; Nelson GW; Haripershad S; Naicker T
Eur J Pediatr; 2022 Oct; 181(10):3595-3606. PubMed ID: 35920919
[TBL] [Abstract][Full Text] [Related]
7. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management.
Bierzynska A; McCarthy HJ; Soderquest K; Sen ES; Colby E; Ding WY; Nabhan MM; Kerecuk L; Hegde S; Hughes D; Marks S; Feather S; Jones C; Webb NJ; Ognjanovic M; Christian M; Gilbert RD; Sinha MD; Lord GM; Simpson M; Koziell AB; Welsh GI; Saleem MA
Kidney Int; 2017 Apr; 91(4):937-947. PubMed ID: 28117080
[TBL] [Abstract][Full Text] [Related]
8. Steroid-resistant nephrotic syndrome: impact of genetic testing.
Kari JA; El-Desoky SM; Gari M; Malik K; Vega-Warner V; Lovric S; Bockenhauer D
Ann Saudi Med; 2013; 33(6):533-8. PubMed ID: 24413855
[TBL] [Abstract][Full Text] [Related]
9. WT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome.
Ramanathan AS; Vijayan M; Rajagopal S; Rajendiran P; Senguttuvan P
Mol Cell Biochem; 2017 Feb; 426(1-2):177-181. PubMed ID: 27885584
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome.
Wang F; Zhang Y; Mao J; Yu Z; Yi Z; Yu L; Sun J; Wei X; Ding F; Zhang H; Xiao H; Yao Y; Tan W; Lovric S; Ding J; Hildebrandt F
Pediatr Nephrol; 2017 Jul; 32(7):1181-1192. PubMed ID: 28204945
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.
Santín S; Tazón-Vega B; Silva I; Cobo MÁ; Giménez I; Ruíz P; García-Maset R; Ballarín J; Torra R; Ars E;
Clin J Am Soc Nephrol; 2011 Feb; 6(2):344-54. PubMed ID: 20947785
[TBL] [Abstract][Full Text] [Related]
12. Response to First Course of Intensified Immunosuppression in Genetically Stratified Steroid Resistant Nephrotic Syndrome.
Mason AE; Sen ES; Bierzynska A; Colby E; Afzal M; Dorval G; Koziell AB; Williams M; Boyer O; Welsh GI; Saleem MA;
Clin J Am Soc Nephrol; 2020 Jul; 15(7):983-994. PubMed ID: 32317330
[TBL] [Abstract][Full Text] [Related]
13. Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome.
Chernin G; Heeringa SF; Gbadegesin R; Liu J; Hinkes BG; Vlangos CN; Vega-Warner V; Hildebrandt F
Pediatr Nephrol; 2008 Sep; 23(9):1455-60. PubMed ID: 18543005
[TBL] [Abstract][Full Text] [Related]
14. TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype.
Gigante M; Caridi G; Montemurno E; Soccio M; d'Apolito M; Cerullo G; Aucella F; Schirinzi A; Emma F; Massella L; Messina G; De Palo T; Ranieri E; Ghiggeri GM; Gesualdo L
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1626-34. PubMed ID: 21734084
[TBL] [Abstract][Full Text] [Related]
15. Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience.
Bińczak-Kuleta A; Rubik J; Litwin M; Ryder M; Lewandowska K; Taryma-Leśniak O; Clark JS; Grenda R; Ciechanowicz A
Bosn J Basic Med Sci; 2014 May; 14(2):89-93. PubMed ID: 24856380
[TBL] [Abstract][Full Text] [Related]
16. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2).
Hinkes BG; Mucha B; Vlangos CN; Gbadegesin R; Liu J; Hasselbacher K; Hangan D; Ozaltin F; Zenker M; Hildebrandt F;
Pediatrics; 2007 Apr; 119(4):e907-19. PubMed ID: 17371932
[TBL] [Abstract][Full Text] [Related]
17. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.
Sadowski CE; Lovric S; Ashraf S; Pabst WL; Gee HY; Kohl S; Engelmann S; Vega-Warner V; Fang H; Halbritter J; Somers MJ; Tan W; Shril S; Fessi I; Lifton RP; Bockenhauer D; El-Desoky S; Kari JA; Zenker M; Kemper MJ; Mueller D; Fathy HM; Soliman NA; ; Hildebrandt F
J Am Soc Nephrol; 2015 Jun; 26(6):1279-89. PubMed ID: 25349199
[TBL] [Abstract][Full Text] [Related]
18. Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children.
Frishberg Y; Rinat C; Megged O; Shapira E; Feinstein S; Raas-Rothschild A
J Am Soc Nephrol; 2002 Feb; 13(2):400-405. PubMed ID: 11805168
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A responsive congenital nephrotic syndrome with single heterozygous variants in NPHS1, NPHS2, and PLCE1.
Eichinger A; Ponsel S; Bergmann C; Günthner R; Hoefele J; Amann K; Lange-Sperandio B
Pediatr Nephrol; 2018 Jul; 33(7):1269-1272. PubMed ID: 29663071
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
